Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28488744 | 0.82 | KDM4E (0.50) | KDM4ELMNA | |
| SCHEMBL952092 | 0.81 | NAAA (0.37) | LMNACYP1A2 | |
| SCHEMBL1537296 | 0.79 | GRIN2D (0.33) | KDM4ELMNACYP1A2 | |
| SCHEMBL3253032 | 0.79 | TP53 (0.33) | KDM4ELMNACYP1A2 | |
| SCHEMBL186138 | 0.79 | GRIN2D (0.33) | KDM4ELMNACYP1A2 | |
| SCHEMBL951592 | 0.79 | FAAH (0.30) | — | |
| SCHEMBL3975721 | 0.77 | TP53 (0.32) | KDM4ELMNACYP1A2 | |
| SCHEMBL4215465 | 0.77 | TP53 (0.32) | KDM4ELMNACYP1A2 | |
| SCHEMBL4215424 | 0.77 | TP53 (0.32) | KDM4ELMNACYP1A2 | |
| SCHEMBL1443592 | 0.77 | LMNA (0.30) | KDM4ELMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100204324-A1 | Optically Active N-(Alpha-Mercaptopropionyl)Glycine | NANJING SANHOME PHARMACEUTICAL CO., LTD. (CN) | 2010-08-12 | — | — | US | claimed |
| EP-2181984-A1 | AN OPTICALLY ACTIVE N- (alpha-MERCAPTOPROPIONY) GLYCINE | Nanjing Sanhome Pharmaceutical Co., Ltd. (CN) | 2010-05-05 | — | — | EP | claimed |
| US-20100204324-A1 | Optically Active N-(Alpha-Mercaptopropionyl)Glycine | NANJING SANHOME PHARMACEUTICAL CO., LTD. (CN) | 2010-08-12 | — | — | US | disclosed |
| EP-2181984-A1 | AN OPTICALLY ACTIVE N- (alpha-MERCAPTOPROPIONY) GLYCINE | Nanjing Sanhome Pharmaceutical Co., Ltd. (CN) | 2010-05-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204324-A1 | Optically Active N-(Alpha-Mercaptopropionyl)Glycine | GNMT, MGST1, GSTP1 | KDM4E 4262/4885LMNA 2317/4885CYP1A2 178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.